Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

A dose-response relationship of smoking with tuberculosis infection: A cross-sectional study among 21008 rural residents in China

  • Haoran Zhang ,

    Contributed equally to this work with: Haoran Zhang, Henan Xin

    Affiliation MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Centre for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

  • Henan Xin ,

    Contributed equally to this work with: Haoran Zhang, Henan Xin

    Affiliation MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Centre for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

  • Xiangwei Li,

    Affiliation MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Centre for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

  • Hengjing Li,

    Affiliation MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Centre for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

  • Mufei Li,

    Affiliation MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Centre for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

  • Wei Lu,

    Affiliation Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, China

  • Liqiong Bai,

    Affiliation Hunan Provincial Institute of Tuberculosis Prevention and Control, Changsha, China

  • Xinhua Wang,

    Affiliation Gansu Provincial Center for Diseases Control and Prevention, Lanzhou, China

  • Jianmin Liu,

    Affiliation The Sixth People’s Hospital of Zhengzhou, Zhengzhou, China

  • Qi Jin,

    Affiliation MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Centre for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

  • Lei Gao

    gaolei@ipbcams.ac.cn

    Affiliation MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Centre for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Abstract

Objectives

China has high burden on both of tuberculosis (TB) and tobacco use. This study aims to explore the potential link between smoking and TB infection using baseline survey data of a large-scale population-based prospective study in rural China

Methods

Between July 1 and Sept 30, 2013, based on the baseline survey of a population-based, prospective study in rural China, the relationship between smoking and TB infection, assessed by interferon-gamma release assays (IGRA), was investigated among the total study population and only among those smokers, respectively.

Results

A total of 21,008 eligible rural registered residents (≥ 5 years old) from 4 rural sites were included in the analysis. Ever-smokers were more likely to be QuantiFERON-TB Gold In-Tube (QFT) positive than never smokers with an adjusted odds ratio (OR) of 1.34 (95% confidence interval (CI): 1.21–1.49). Among ever smokers, a significant linear dose–response relation was observed between duration of smoking (by years) and QFT positivity (p < 0.001). Stratified analysis suggested that such an association was not influenced by gender and age. Evidence for interaction of smoking status with age was found.

Conclusions

Our results provide further evidence to support smoking might increase host susceptibility to TB infection. Populations under high risk of infection, such as elderly smokers, should be prior to TB infection controlling under a premise of community level intervention.

Introduction

The epidemics of tobacco smoking and tuberculosis (TB) are colliding, and increasing evidence showed smoking was associated with an increased risk of active TB [15]. However, the relation between smoking and TB infection has not been widely studied especially in China [67]. In spite of the accumulated evidence demonstrating a causal relationship between smoking and TB infection, whether smoking cessation in a community level could contribute to TB controlling is still being debated. Because most of the published studies were limited to special populations at high risk of TB infection, including prisoners [89], migrant workers [1011], immigrants [1213], and the homeless [14]. Furthermore, several studies even reported a negative association between cigarette smoking and TB infection [1517]. Therefore, population-based data is urgent needed. Recently, we reported a causal link between smoking and TB infection in a population-based multicenter prospective study conducted in rural China. The annual risk of TB infection among ever-smokers has been found to be 1.53 fold higher as compared to never-smokers [18]. However, further more detailed analysis in the impact of smoking on TB infection was limited due to small sample size of the observed recently infected cases.

Therefore, this study aimed to investigate the association between smoking and TB infection in a community level based on the baseline survey of a large-scale population-based prospective study in rural China.

Materials and methods

Study participants

This cross-sectional study was based on the baseline survey of a multicenter prospective cohort study in rural China conducted between July 1st and September 30th, 2013, which has been reported in detail in elsewhere [19]. Registered rural residents at the four study sites were the target populations of the present and previous study. The study sites were selected based on a wide range of local TB epidemiology, economic conditions and geographic diversity (S1 Table) [19]. The inclusion criteria of the study participants were: resident population aged 5 years and above (birth prior to 1 June, 2008); resident population (more than 6 months’ residence in study site in the past year); provision of voluntary written informed consent. The exclusion criteria were suspected or current active tuberculosis (According to WHO guidelines, bacteriological confirmed TB cases (positive for sputum-smear or/and culture or/and X-pert MTB/RIF) or clinically diagnosed case of TB (cases diagnosed on the basis of chest digital radiography abnormalities without laboratory confirmation) were defined as active TB case), self-reported history of tuberculosis, and pregnancy.

Determination of TB infection

TB infection was tested using both tuberculin skin test (TST) and interferon-γ release assay (IGRA). IGRA result was used to determine TB infection status in the present study because our previous results proved TST results were affected by several factors including age, Bacillus Calmette-Guerin (BCG) vaccination and exposure to non-tuberculosis mycobacterium. QuantiFERON-TB Gold In-Tube (QFT, QIAGEN, USA), a commercial IGRA, was performed as recommended by the manufacturer using a cutoff value of ≥ 0.35 IU/ml.

Data collection

The study protocol was approved by the ethics committees of the Institute of Pathogen Biology, Chinese Academy of Medical Sciences (No: IPB-2013-5). Upon explanation of the study protocol, written informed consent was obtained from the participant or the legal guardian for all study participants. For each study participant, socio-demographic information was collected by a standardized questionnaire administered by trained interviewers. The questionnaire contained items on demographic characteristics (age, gender, educational level, and household per capita income (RMB)), alcohol consumption, cigarette smoking, history of reported tuberculosis disease, history of type 2 diabetes mellitus (T2DM) (With a self-reported history and/or fast blood glucose higher than 7.0 mmol/L at baseline examination) and history of close contact with a patient with tuberculosis. The following questions included items on smoking conditions: (1) Smoking status: never smoked (smoked less than 5 cigarettes per month or never smoked) and ever smoked (smoked 5 or more cigarettes per month). Ever smokers were further categorized as current smokers and former smokers. The information of duration of abstaining from smoking was collected. (2) Age of smoking onset. (3) Type of cigarette smoking. Two types of cigarette smoking are prevalent in rural China: filter tip cigarettes and sun-cured tobacco without filter tip. The latter was self-made by dried tobacco leaf rolling in a blank paper. (4) Duration of smoking by years and number of cigarettes per day: These exposure were converted into categorical variables for analysis (≤ 10 years, 10–20 years, 20–30 years, 30–40 years, 40–50 years, > 50 years) and (1–5, 6–10, 11–19, and ≥ 20 cigarettes per day), respectively. Body mass index (BMI) was calculated as weight over height squared (kg/m2), and was further categorized as underweight (< 18.5 kg/m2), normal weight (18.5 to 24.0 kg/m2), overweight (24.0 to 28.0 kg/m2), or obese (≥ 28.0 kg/m2) [20].

Statistical analysis

Data analyses were performed using SAS 9.2 (SAS Institute Inc., NC, USA). The Pearson’s χ2 test was used to compare the categorical variables. Variables with p < 0.05 in the univariate analysis were all included in the multivariable models based on our previous hypothesis Stepwise multiple logistic regression analysis was used to identify the variables independently associated with QFT positivity, the significance level for the variables stayed in the model was 0.05. The associations between TB infection and self-reported history of cigarette smoking were assessed by means of odds ratios (OR) and 95% confidence intervals (CI). Cochran–Armitage (chi-square) tests were used to explore TB infection trends with cigarette intensity. Evidence for interaction of smoking status with gender, age, BMI and TB contact history was assessed using the likelihood ratio test (LRT) by comparing logistic regression models with and without an interaction term. In additional sensitivity analyses, the association between TB infection and self-reported history of cigarette smoking was evaluated after excluding 5–19 years old people.

Results

A total of 21,022 eligible participants from four study sites completed baseline survey, 21,008 of them were included in this study after excluding 14 with missing data on smoking. Basic characteristics of the study population with respect to smoking status were shown in Table 1. In total, more than half (53.71%, 11,284/21,008) were females and the age ranged from 5 to 99 years with a median age 46 years (interquartile range [IQR]: 27–59 years). Among the study participants, 24.73% (5195/21008) were ever-smokers (4,835 (24.17%) were current-smokers, 360 (1.80%) were former-smokers), and 15,813 (75.27%) had never smoked. Ever-smokers reported higher educational levels and household incomes than never-smokers. BMI distribution showed that 2089 (40.21%) ever- and 5558 (35.15%) never smokers were overweight or obese. Ever smokers (53.38%, 2773/5195) were more likely to drink alcohol than never-smokers (7.70%, 1,217/15,813) (p < 0.001). 235 (4.53%) ever- and 579 (3.66%) never- smokers had a history of close contact with TB patients, respectively. 6.74% (350/5195) ever smokers and 4.22% (667/15813) never smokers had a self-reported history of T2DM or with a baseline fast blood glucose level ≥ 7.0 mmol/L. The QFT positivity for ever-smokers and never-smokers was 28.26% (1468/5195) and 15.72% (2,486/15,813), respectively (p < 0.001).

thumbnail
Table 1. Characteristics of the total study population by smoking status.

https://doi.org/10.1371/journal.pone.0175183.t001

Univariate and multivariate analysis of QFT positivity were conducted firstly among total study population (Table 2). Factors significantly associated with QFT positivity were male sex, increasing age, a BMI of 28.0 kg/m2 or more, ever smoked and history of close contact with TB patients. The risk of QFT positivity among ever-smokers was 1.34 times higher than never-smokers (95% CI: 1.21–1.49) in multivariate analysis. After classified by gender and age groups, ever-smokers were still more likely to be QFT positive than never smokers as depicted in Fig 1.

thumbnail
Fig 1.

Distribution of QFT positivity among ever-smokers and never-smokers by smoking status, gender (1A) and age (1B). After classified by gender and age groups, ever-smokers were still more likely to be QFT positivity than never-smokers (*: p < 0.05, **: p < 0.01). Abbreviations: QFT = QuantiFERON-TB Gold In-Tube.

https://doi.org/10.1371/journal.pone.0175183.g001

thumbnail
Table 2. Identification of the factors independently associated with QFT positivity in the total study population.

https://doi.org/10.1371/journal.pone.0175183.t002

Factors associated with QFT positivity among smokers were shown in Table 3. An increasing TB infection risk was observed to be positively related to ages of 60 years or older, history of close contact with TB patients and duration of smoking years. In addition, as shown in Fig 2, a significant dose–response relation between QFT positivity and duration of smoking years was observed among smokers (p trend = 0.001).

thumbnail
Fig 2. Association of QFT positivity with smoking years among smokers.

Multiple logistic regression analysis was conducted to assess the association of smoking years with QFT positivity. Variables with p < 0.05 in univariate analysis were included in the model. Gender, age, education level, history of close contact with tuberculosis patients, alcohol drinking, number of cigarettes smoked per day were adjusted. Adjusted odds ratio (ORs) and the 95% confidence intervals (CIs) were given in the figure. Abbreviations: CI = confidence interval; QFT = QuantiFERON-TB Gold In-Tube.

https://doi.org/10.1371/journal.pone.0175183.g002

thumbnail
Table 3. Association analysis for QFT positivity among smokers.

https://doi.org/10.1371/journal.pone.0175183.t003

As shown in Table 4, we found evidence of modification effect by age (p for interaction < 0.001) with an OR ranged from 3.44 (1.16, 10.16) for those aged less than 19 to an OR of 1.31 (1.10, 1.55) for those older than 60. We did not observe a modification effect of gender (p for interaction, 0.842), BMI (p for interaction, 0.838) or history of TB contacts (p for interaction, 0.931). In additional sensitivity analyses, excluding 3556 subjects who were 5–19 years old did not materially alter the results (S2 and S3 Tables).

thumbnail
Table 4. The association of QFT positivity and smoking status by age, gender and TB contact history among total study populations.

https://doi.org/10.1371/journal.pone.0175183.t004

Discussion

In this large cross-sectional analysis among 21,008 participants in rural China, ever smoking was found to be significantly associated with TB infection. Among smokers, smoking years was identified as an independent risk factor which was strongly related to TB infection in a dose-response manner. Our results suggested that the development of smoking bans in China might benefit TB control as well. High risk populations for TB infection, such as smoking elderly found in this study, might be potential target populations for TB infection monitoring and management in China.

The World Health Organization published a monograph to announce the integration of tobacco control into TB programs in 2007 [21]. However, the impact of smoking on TB infection has not been clearly estimated. China not only has the greatest number of smokers but also carry some of the highest smoking rates. The geographic overlap between rural areas of China with a higher prevalence of cigarette smoking and regions with higher prevalence of latent and active TB is striking and complex, but the potential for significant public health impact is unparalleled. Also, based on the results of our previous study, 13.5%-19.8% of participants were QFT positive in rural China. This may represent an enormous reservoir for tuberculosis transmission and rural areas are a logical and strategic focus for intervention. The results in our investigation were consistent with several studies in population survey settings such as South Africa [22], America [23] which found a positive link between smoking and TST positivity. More importantly, our results might be more robust after excluding the potential interferences from BCG vaccination and non-tuberculosis mycobacteria (NTM) by using IGRA. However, by contrast with the increasing risk of TB infection among smokers in our study, such a relation was not found in the study performed in Zambia and South Africa [15, 17]. The different characteristics of the study populations might account for the disparity. Both of the studies examined the influence of smoking on QFT results in human immunodeficiency virus (HIV) infections. The decreased sensitivity of QFT test in immune-suppressed individuals underestimated the prevalence of TB infection and might finally lead to bias [24]. In addition, smoking habit might be different among populations at higher risk of HIV infection and might be changed after HIV infection acquisition. Therefore, we should take care to generalize the findings from the specific population to the general population.

This study showed that there was a positive dose-response relationship between smoking years and TB infection. The adverse effects of cigarette smoking on pulmonary immunity might explain the susceptibility of smoking population to TB infection [25]. Cigarette smoking may attenuate host defense mechanisms by preventing expansion and activation of pathogen-specific CD4+ T-cells and reducing the numbers of IFN-γ-producing adenoid-specific CD4+ and CD8+ T-cells [26]. Cumulative stimulation of cigarette smoking might selectively down-regulates the production of IL-12 and TNF-α. Simultaneously, nicotine could turn off production of TNF-α by macrophages while leaving the secretion of IL-10 intact [27]. However, it is worth concern that the aged population probably had longer duration and/or higher intensity in cigarette smoking and the lung structure impairment in aged patients may also increase their susceptibilities to TB infection. A study from Taiwan found evidence of effect modification by age because the effect of current smoking on active TB disappeared among those aged 65 or older [28]. Evidence of effect modification between age and smoking were also found in our study. Unlike the study from Taiwan, the prevalence of TB infection increased from 2.79% among < 20 years’ never-smokers to 39.32% among ≥ 60 years’ ever-smokers (classified by 20 years). The effect of smoking on TB infection was always statistically significant although it decreased with age, which hinted the necessity of advocating smoking cessation among older smokers. Otherwise, in contrast to several studies [8, 11], our study failed to find a correlation between numbers of cigarettes smoked per day and TB infection among smoking populations. There are two explanations for this discrepancy. Firstly, our large sample size gives us the opportunity to stratify this analysis among smokers, but the former studies mainly used never-smokers as control. Second, co-linearity might exist between years of smoking and numbers of cigarettes smoked due to the potential tendency for smokers to smoke more and more as times went on. We verified our hypotheses by analyzing the effect of numbers of cigarettes smoked per day in whole population. Comparing with never-smokers, a dose-effect association was observed with OR ranged from 1.19 to 1.44 after controlling for age, gender, BMI and close contact history (S4 Table). However, the associations were non-significant when adding smoking years into the model. But the effect of smoking years was still significant in such a model. Therefore, smoking years might be a better indicator to reflect the impact of cigarette intensity on TB infection.

Our findings should be interpreted with consideration of the following limitations. First, the cross-sectional analysis could not absolutely determine the causal link between cigarette smoking and TB infection. During the follow-up period of the study, the relationship between smoking and the risk of TB infection acquisition will be further studied to clarify this important issue. Second, smoking status was self-reported rather than determined by biochemical methods. A previous systematic review showed trends of underestimation when smoking prevalence was based on self-report compared to cotinine-assessed [29]. Although a serious of related questions on smoking were collected which might reduce the possibility of such information bias, but we couldn’t exclude it completely. Thirdly, Second Hand Smoke (SHS) exposure or passive smoking [30] and air pollution [6] had been reported to be associated with elevated risk for TB infection. While we failed to clarify this effect as we didn’t collect related information.

Conclusions

Despite of the limitations, our findings support that cigarette smoking was independently associated with increased risk of TB infection. More attention should be attached to smokers, especially elderly smokers, as one potential target population for TB infection controlling in rural China. Reinforced programs to reduce cigarette use or development of regimen on tobacco cessation might contribute to lighten the burden of TB infection. In addition, active case finding among populations with specific risks such as smokers [31], close contacts [32], diabetes [33] should be strengthened as well.

Supporting information

S1 Table. Population sampling among the study sites at the baseline survey in 2013.

https://doi.org/10.1371/journal.pone.0175183.s001

(DOC)

S2 Table. Association analyses for QFT positivity among study population aged 20 years or older.

https://doi.org/10.1371/journal.pone.0175183.s002

(DOC)

S3 Table. Association analysis for QFT positivity among smokers aged 20 years or older.

https://doi.org/10.1371/journal.pone.0175183.s003

(DOC)

S4 Table. Multivariate analysis of QFT positivity classified by number of cigarettes per day.

https://doi.org/10.1371/journal.pone.0175183.s004

(DOC)

Acknowledgments

We appreciate Prof. Lixia Wang and Prof. Shuigao Jin from Chinese Center for Disease Prevention and Control, and Prof. Yude Chen from Peking University for their help on study implement and data analysis. We thank Dr. Shiming Cheng and Dr. Liya Wan from Chinese Anti-tuberculosis Association for their support on study design. We thank all the investigators from the study sites for their contribution to the site work for baseline survey.

Author Contributions

  1. Conceptualization: LG QJ.
  2. Data curation: HRZ HNX.
  3. Formal analysis: HRZ HNX LG.
  4. Funding acquisition: LG.
  5. Investigation: HRZ HNX XWL MFL HJL WL LQB XHW JML.
  6. Methodology: QJ LG.
  7. Project administration: WL LQB XHW JML.
  8. Resources: WL LQB XHW JML.
  9. Software: QJ LG.
  10. Supervision: QJ LG.
  11. Validation: QJ LG.
  12. Visualization: HRZ HNX.
  13. Writing – original draft: HRZ HNX LG.
  14. Writing – review & editing: HRZ HNX LG.

References

  1. 1. Aryanpur M, Masjedi MR, Mortaz E, Hosseini M, Jamaati H, Tabarsi P, et al. Intention to Quit Smoking and Associated Factors in Smokers Newly Diagnosed with Pulmonary Tuberculosis. Tanaffos. 2016; 15(1): 17–24. pmid:27403174
  2. 2. Bai KJ, Lee JJ, Chien ST, Suk CW, Chiang CY. The Influence of Smoking on Pulmonary Tuberculosis in Diabetic and Non-Diabetic Patients. PLoS One. 2016; 11(6): e0156677. pmid:27270725
  3. 3. Aryanpur M, Masjedi MR, Hosseini M, Mortaz E, Tabarsi P, Soori H, et al. Cigarette smoking in patients newly diagnosed with pulmonary tuberculosis in Iran. Int J Tuberc Lung Dis. 2016; 20(5): 679–684. pmid:27084824
  4. 4. Loddenkemper R, Brönnecke M, Castell S, Diel R. Tuberculosis and Tobacco Smoking. Pneumologie. 2016; 70(1): 17–22. pmid:26789428
  5. 5. Pednekar MS, Gupta PC. Prospective study of smoking and tuberculosis in India. Prev Med. 2007; 44(6): 496–498. pmid:17391745
  6. 6. Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PloS Med. 2007; 4(1): e20. pmid:17227135
  7. 7. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Archives Int Med. 2007; 167 (4): 335–342.
  8. 8. Hussain H, Akhtar S, Nanan D. Prevalence of and risk factors associated with Mycobacterium tuberculosis infection in prisoners, North West Frontier Province, Pakistan. Int J Epidemiol. 2003; 32 (5): 794–799. pmid:14559752
  9. 9. Anderson RH, Sy FS, Thompson S, Addy C. Cigarette smoking and tuberculin skin test conversion among incarcerated adults. Am J Prev Med. 1997; 13(3): 175–181. pmid:9181204
  10. 10. McCurdy SA, Arretz DS, Bates RO. Tuberculin reactivity among California Hispanic migrant farm workers. Am J Ind Med. 1997; 32 (6): 600–605. pmid:9358916
  11. 11. Plant AJ, Watkins RE, Gushulak B, O'Rourke T, Jones W, Streeton J, et al. Predictors of tuberculin reactivity among prospective Vietnamese migrants: the effect of smoking. Epidemiol Infect. 2002; 128 (1): 37–45. pmid:11895089
  12. 12. Singh M, Mynak ML, Kumar L, Mathew JL, Jindal SK. Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis. Arch Dis Child. 2005; 90 (6): 624–628. pmid:15908630
  13. 13. Solsona J, Cayla JA, Nadal J, Bedia M, Mata C, Brau J, et al. Screening for tuberculosis upon admission to shelters and free-meal services. Eur J Epidemiol. 2001; 17 (2): 123–128. pmid:11599684
  14. 14. Nisar M, Williams CS, Ashby D, Davies PD. Tuberculin testing in residential homes for the elderly. Thorax. 1993; 48(12): 1257–1260. pmid:8303634
  15. 15. Shanaube K, Hargreaves J, Fielding K, Schaap A, Lawrence KA, Hensen B, et al. Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa. PloS One. 2011; 6 (4): e18206. pmid:21483746
  16. 16. He G, Li Y, Zhao F, Wang L, Cheng S, Guo H, et al. The Prevalence and Incidence of Latent Tuberculosis Infection and Its Associated Factors among Village Doctors in China. PloS One. 2015; 10(5): e0124097. pmid:25996960
  17. 17. Oni T, Gideon HP, Bangani N, Tsekela R, Seldon R, Wood K, et al. Smoking, BCG and employment and the risk of tuberculosis infection in HIV-infected persons in South Africa. PloS One. 2012; 7 (10): e47072. pmid:23056584
  18. 18. Gao L, Bai L, Liu J, Lu W, Wang X, Li X, et al. Annual risk of tuberculosis infection in rural China: a population-based prospective study. Eur Respir J. 2016; 48(1): 168–178. pmid:27230438
  19. 19. Gao L, Lu W, Bai L, Wang X, Xu J, Catanzaro A, et al. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis. 2015; 15(3): 310–319. pmid:25681063
  20. 20. Ministry of Health of the People's Republic of China. Criteria of Weight for Adults (WS/T428-2013); 2013.
  21. 21. World Health Organization. International Union against Tuberculosis and Lung Disease. A WHO/the Union monograph on TB and tobacco control: joining efforts to control two related global epidemics. 2007.
  22. 22. den Boon S, van Lill SW, Borgdorff MW, Verver S, Bateman ED, Lombard CJ, et al. Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax. 2005; 60(7): 555–557. pmid:15994262
  23. 23. Horne DJ, Campo M, Ortiz JR, Oren E, Arentz M, Crothers K, et al. Association between smoking and latent tuberculosis in the U.S. population: an analysis of the National Health and Nutrition Examination Survey. PloS One. 2012; 7(11): e49050. pmid:23145066
  24. 24. Santin M, Munoz L, Rigau D. Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis. PloS One. 2012; 7 (3): e32482. pmid:22403663
  25. 25. Feng Y, Kong Y, Barnes PF, Huang FF, Klucar P, Wang X, et al. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Immun. 2011; 79 (1): 229–237. pmid:20974820
  26. 26. Robbins CS, Dawe DE, Goncharova SI, Pouladi MA, Drannik AG, Swirski FK, et al. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Resp Cell Mol. 2004; 30 (2): 202–211.
  27. 27. Matsunaga K, Klein TW, Friedman H, Yamamoto Y. In vitro therapeutic effect of epigallocatechin gallate on nicotine-induced impairment of resistance to Legionella pneumophila infection of established MH-S alveolar macrophages. J Infect Dis. 2002; 185 (2): 229–236. pmid:11807697
  28. 28. Lin HH, Ezzati M, Chang HY, Murray M. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Resp Crit Care. 2009; 180 (5): 475–480.
  29. 29. Connor Gorber S, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009; 11 (1): 12–24. pmid:19246437
  30. 30. Patra J, Bhatia M, Suraweera W, Morris SK, Patra C, Gupta PC, et al. Exposure to Second-Hand Smoke and the Risk of Tuberculosis in Children and Adults: A Systematic Review and Meta-Analysis of 18 Observational Studies. PLoS Med. 2015; 12 (6):e1001835. pmid:26035557
  31. 31. Wei X, Zou G, Chong MK, Xu L. An intervention of active TB case finding among smokers attending routine primary care facilities in China: an exploratory study. Trans R Soc Trop Med Hyg. 2015; 109 (9): 545–552. pmid:26246249
  32. 32. Zhang X, Wei X, Zou G, Walley J, Zhang H, Guo X, et al. Evaluation of active tuberculosis case finding through symptom screening and sputum microscopy of close contacts in Shandong, China. Trop Med Int Health. 2011; 16 (12): 1511–1517. pmid:21848577
  33. 33. Lin Y, Li L, Mi F, Du J, Dong Y, Li Z, et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health. 2012; 17 (10):1302–1308. pmid:22830951